FDC Ltd, a Rs.600 crore plus pharma company, has notched up net profit growth of 4.4 per cent during the third quarter ended December 2010 to Rs.32.09 crore from Rs.30.74 crore in the corresponding period of last year. Its EBDITA, however, declined by 4.6 per cent to Rs.43.72 crore from Rs.45.81 crore. The company's net sales increased by 10.6 per cent to Rs.163.58 crore from Rs.147.90 crore. The earnings per share worked out to Rs.1.72 as compared to Rs.1.65 in the last period.


For the first nine months ended December 2010, FDC's net sales increased by 11.5 per cent to Rs.540.56 crore from Rs.484.85 crore in the similar period of last year. Its net profit remained almost flat at Rs.117.76 crore as compared to Rs.115.53 crore.


The board of directors have decided to buyback the equity shares of the company, up to a maximum offer price of Rs.135 per equity share, from the open market through stock exchanges, subject to, a maximum offer size of Rs.50 crore .